September 14, 2026

FDA approves muscle-targeted SMA therapy

The therapy inhibits myostatin signaling and is used with survival motor neuron 2-targeted treatment.

MDSpire News

August 27, 2026

10 states that support physician work-life balance

These 10 states have paid family or medical leave programs and health, wellness, peer support, or monitoring resources available to physicians or other health professionals.

MDSpire News

July 30, 2026

Top 10 Evidence-Based Essentials in Orthopedic Medicine

A structured framework of guidelines, trials, therapies, and tools used in clinical practice.

MDSpire News

July 17, 2026

FDA Approves New Iohexol Vials

The approval includes additional 300 mg iodine/mL and 350 mg iodine/mL vial presentations.

MDSpire News

July 10, 2026

10 CMS and FDA Actions Affecting Care in 2026

From Medicare payment updates to drug approvals and device access, these federal actions may affect reimbursement, prescribing, patient access, and clinical workflows.

MDSpire News

July 02, 2026

Simplified Bone Age Method May Aid Review

Single-bone approach showed close agreement with Greulich-Pyle assessments in adolescents, particularly among experienced raters

MDSpire News

June 24, 2026

No Short-Term Brain Changes in Youth Soccer

Researchers tracked cognitive, behavioral, imaging, and biomarker outcomes in 129 adolescent athletes across one season.

MDSpire News

June 18, 2026

Top 10 FDA Recalls Physicians Should Know

A structured overview of recent FDA recalls, corrections, and alerts involving medications, ventilators, insulin delivery systems, cardiovascular devices, anesthesia products, and other equipment used in clinical practice.

MDSpire News

June 15, 2026

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.

MDSpire News

June 08, 2026

FDA Expands Marstacimab Indication in Hemophilia A and B

Phase 3 BASIS and BASIS KIDS data supported the expanded indication across pediatric and inhibitor-pretreated populations.

MDSpire News